Latest Asx Filings News

Westgold Resources reported a 72% jump in revenue to $624 million in H1 FY25, driven by increased gold production and higher prices, but posted a net loss after tax due to significant one-off acquisition expenses.

Pengana Capital Group reports a rise in Funds Under Management to $3.64 billion as of January 31, 2025, following significant distributions to investors. The firm’s half-year audited results are due next month, setting the stage for further insights.

Siren Gold has restarted drilling at its Sams Creek Project in New Zealand, aiming to expand its 824,000-ounce gold resource by targeting deeper porphyry structures and fold hinges. The company plans a focused drilling campaign and mining study in 2025 to unlock further value.

Westgold Resources reports a sharp revenue increase driven by higher gold prices and the Karora acquisition, yet posts a net loss for the half-year ending December 2024. The company also declares a fully franked dividend amid rising costs.

WAM Capital Limited has announced a six-month ordinary dividend of AUD 0.0775 per share, partially franked at 60%, payable on April 30, 2025. The company’s Dividend Reinvestment Plan remains fully available to shareholders.

Mirvac Group reports a 2% revenue increase and a remarkable 100% rise in profit attributable to stapled securityholders for H1 2024, even as operating profit after tax declines by 6%.

Imugene’s Phase 1b trial of azer-cel, an off-the-shelf CD19 CAR T therapy, reports a 57% complete response rate in heavily pretreated diffuse large B-cell lymphoma patients, signaling a promising new option in a challenging cancer landscape.

AMP Limited has announced a modest dividend of AUD 0.01 per share for the six months ending December 2024, with 20% franked and 80% unfranked components, signaling steady shareholder returns amid evolving market conditions.

GQG Partners Inc. has announced a quarterly ordinary dividend of USD 0.0378 per CDI, payable on March 27, 2025, with an option for Australian dollar conversion at a specified exchange rate.

AVITA Medical reported a strong 30% increase in Q4 2024 commercial revenue and amended its credit agreement with OrbiMed to adjust revenue covenants through 2026. The company is poised for significant growth with new product rollouts and expects profitability by year-end 2025.

AVITA Medical's Q4 2024 earnings reveal strong commercial growth alongside the launch of Cohealyx, a novel collagen-based skin substitute that promises to transform acute wound care.

BPM Minerals has commenced a significant 6,000m aircore drilling program at its Claw Gold Project in Western Australia, aiming to extend known gold mineralisation along an 8km corridor adjacent to Capricorn Metals' Mount Gibson Gold Project.